Latest From BioClinica
The wave of merger and acquisitions that has washed through the contract research organization sector this year is set to continue as the pharmaceutical industry increasingly turns to outsourcing for its clinical needs.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Overwhelming number of stakeholders urge FDA to choose the Clinical Data Interchange Standards Consortium’s Operational Data Model instead of the competing Health Level 7 standard for clinical data submissions.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Senior Management
John HUbbard, PhD, CEO
Ted Kaminer, SVP, CFO
Mark Endres, SVP, Global Bus. Dev.
- Contact Info
Phone: (267) 757-3000
826 Newtown-Yardley Rd.
Newtown, PA 18940
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.